News
6h
Fintel on MSNCantor Fitzgerald Initiates Coverage of InflaRx N.V. (IFRX) with Overweight RecommendationFintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of InflaRx N.V. (NasdaqGS:IFRX) with a Overweight ...
6h
Fintel on MSNCantor Fitzgerald Initiates Coverage of BioCryst Pharmaceuticals (BCRX) with Overweight RecommendationFintel reports that on April 29, 2025, Cantor Fitzgerald initiated coverage of BioCryst Pharmaceuticals (NasdaqGS:BCRX) with ...
Potential funding cuts for NOAA and its research partners threaten irreparable harm to climate research and safety ...
The prime example is Tether, a firm that regulators once targeted. Its chief executive recently hobnobbed in Washington with ...
Analysts have recently evaluated Western Digital and provided 12-month price targets. The average target is $71.91, ...
Trump’s most prominent foray into digital assets, however, is his official $Trump memecoin—an official crypto token released ...
A groundbreaking study from the Cambridge Centre for Alternative Finance (CCAF) claims that the United States now dominates ...
Howard Lutnick, the secretary of commerce, has become a go-to for major companies seeking relief from tariffs. But he’s not ...
Markets rally on US-China trade optimism and a $3.6B Tether-SoftBank Bitcoin venture. Bitcoin hits $93,916.87 amid ETF ...
Neither Y2K bust nor WeWork's failure deter SoftBank's mercurial chief Masayoshi Son to venture again into speculative ...
Tesla (TSLA) stock saw a 1.2% rise in early trading on Monday, continuing its upward momentum for a fifth consecutive day.
Zacks Research bumped up Vertex Pharmaceuticals’ Q1 2027 earnings forecast by a thrilling one cent, now expecting $4.24 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results